Skip to main content
. 2014 Oct 10;9(10):e108751. doi: 10.1371/journal.pone.0108751

Figure 5. SVR rates in patients with RVR treated for 16 or 24 weeks in the overall cohort and in HCV genotype 3 patients.

Figure 5

A: All patients had low viral, no signs of cirrhosis, RVR and were recommended for 16 weeks of treatment. B: All patients had low viral, no signs of cirrhosis, RVR and were recommended for 16 weeks of treatment.